{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:48:51Z","timestamp":1760060931346,"version":"build-2065373602"},"reference-count":116,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1053\/j.semdp.2020.07.003","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T03:17:27Z","timestamp":1596165447000},"page":"144-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Myeloid, mast cell, histiocytic and dendritic cell neoplasms and proliferations involving the spleen"],"prefix":"10.1053","volume":"38","author":[{"given":"Sonam","family":"Prakash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvaldo","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.semdp.2020.07.003_bib0001","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41375-018-0077-1","article-title":"Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet","volume":"32","author":"Barbui","year":"2018","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2020.07.003_bib0002","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1756-8722-5-43","article-title":"Splenomegaly in myelofibrosis\u2013new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors","volume":"5","author":"Randhawa","year":"2012","journal-title":"J Hematol Oncol"},{"issue":"10","key":"10.1053\/j.semdp.2020.07.003_bib0003","first-page":"1114","article-title":"Systematic review of atraumatic splenic rupture","volume":"96","author":"Renzulli","year":"2009","journal-title":"BJS (Br J Surg)"},{"issue":"5218","key":"10.1053\/j.semdp.2020.07.003_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/bmj.1.5218.35","article-title":"Spontaneous rupture of the spleen in acute myeloid leukaemia","volume":"1","author":"Flood","year":"1961","journal-title":"Br Med J"},{"issue":"7","key":"10.1053\/j.semdp.2020.07.003_bib0005","first-page":"286","article-title":"Spontaneous rupture of the spleen in chronic myeloid leukaemia","volume":"29","author":"Sarin","year":"1957","journal-title":"J Indian Med Assoc"},{"key":"10.1053\/j.semdp.2020.07.003_bib0006","series-title":"Surgical Pathology of the Lymph Nodes and Related Organs","first-page":"448","article-title":"Diagnosis of lymphoma and lymphoid proliferations in the spleen.","author":"Burke","year":"1995"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0007","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/0008-5472.CAN-09-3783","article-title":"Genetic Analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias","volume":"70","author":"Abdel-Wahab","year":"2010","journal-title":"Cancer Res"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0008","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMc0910063","article-title":"Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms","volume":"362","author":"Green","year":"2010","journal-title":"N Engl J Med"},{"issue":"50","key":"10.1053\/j.semdp.2020.07.003_bib0009","doi-asserted-by":"crossref","first-page":"E5401","DOI":"10.1073\/pnas.1407792111","article-title":"Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms","volume":"111","author":"Rampal","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"10.1053\/j.semdp.2020.07.003_bib0010","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1182\/blood-2011-11-390252","article-title":"Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0011","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10238-020-00616-5","article-title":"Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature","volume":"20","author":"Coltro","year":"2020","journal-title":"Clin Exp Med"},{"issue":"11","key":"10.1053\/j.semdp.2020.07.003_bib0012","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3324\/haematol.2012.080432","article-title":"Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts","volume":"98","author":"Chiaretti","year":"2013","journal-title":"Haematologica"},{"issue":"7","key":"10.1053\/j.semdp.2020.07.003_bib0013","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00000478-198110000-00011","article-title":"Surgical pathology of the spleen: an approach to the differential diagnosis of splenic lymphomas and leukemias. Part II. Diseases of the red pulp","volume":"5","author":"Burke","year":"1981","journal-title":"Am J Surg Pathol"},{"year":"1999","series-title":"Disorders of the Spleen","author":"Neiman","key":"10.1053\/j.semdp.2020.07.003_bib0014"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0015","first-page":"81","article-title":"A simultaneous study of bone marrow, spleen, and liver in chronic myeloid leukemia: evidence for differences in cell composition and karyotypes","volume":"8","author":"Baccarani","year":"1975","journal-title":"Ser Haematol"},{"issue":"1","key":"10.1053\/j.semdp.2020.07.003_bib0016","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0039-6060(97)90259-2","article-title":"Splenectomy in the accelerated or blastic phase of chronic myelogenous leukemia: a single-institution, 25-year experience","volume":"122","author":"Bouvet","year":"1997","journal-title":"Surgery"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0017","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-0609.1969.tb01811.x","article-title":"Differences in the proliferative activity of myelocytes from bone marrow, spleen and peripheral blood in chronic myeloid leukaemia","volume":"6","author":"Brandt","year":"1969","journal-title":"Scand J Haematol"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0018","first-page":"75","article-title":"Comparative studies of bone marrow and extramedullary haemopoietic tissue in chronic myeloid leukemia","volume":"8","author":"Brandt","year":"1975","journal-title":"Ser Haematol"},{"issue":"11\u201312","key":"10.1053\/j.semdp.2020.07.003_bib0019","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s001090050173","article-title":"Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia","volume":"75","author":"Griesshammer","year":"1997","journal-title":"J Mol Med"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0609.1974.tb00240.x","article-title":"Cytogenetic evidence for splenic origin of blastic transformation in chronic myeloid leukaemia","volume":"13","author":"Mitelman","year":"1974","journal-title":"Scand J Haematol"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0021","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1182\/blood.V52.4.828.828","article-title":"Chromosome analysis of spleen and\/or lymph nodes of patients with chronic myeloid leukemia (CML)","volume":"52","author":"Stoll","year":"1978","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0022","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-2964(75)90190-5","article-title":"Differences in marrow and spleen cell karyotype in early chronic myeloid leukaemia","volume":"11","author":"Zaccaria","year":"1975","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1053\/j.semdp.2020.07.003_bib0023","first-page":"1138","article-title":"Marked granulocytic proliferation induced by granulocyte colony-stimulating factor in the spleen simulating a myeloid leukemic infiltrate","volume":"11","author":"Vasef","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.07.003_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-222561","article-title":"Spontaneous splenic rupture as a rare complication of G-CSF injection","volume":"2018","author":"Benguerfi","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.bmt.1705736","article-title":"Splenic rupture in a patient with plasma cell myeloma following G-CSF\/GM-CSF administration for stem cell transplantation and review of the literature","volume":"40","author":"Veerappan","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1053\/j.semdp.2020.07.003_bib0026","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bjh.12461","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms","volume":"162","author":"Sekhar","year":"2013","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.semdp.2020.07.003_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030898","article-title":"Understanding Splenomegaly in Myelofibrosis: association with Molecular Pathogenesis","volume":"19","author":"Song","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1053\/j.semdp.2020.07.003_bib0028","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1182\/blood-2007-07-099184","article-title":"JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis","volume":"110","author":"Barosi","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.semdp.2020.07.003_bib0029","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2014-05-578435","article-title":"Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis","volume":"124","author":"Rumi","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.semdp.2020.07.003_bib0030","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood-2015-03-633404","article-title":"Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib","volume":"126","author":"Patel","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2020.07.003_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2004.02.002","article-title":"Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders","volume":"19","author":"Kralovics","year":"2005","journal-title":"Blood Rev"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0032","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.exphem.2007.10.001","article-title":"Altered SDF-1\/CXCR4 axis in patients with primary myelofibrosis and in the Gata1low mouse model of the disease","volume":"36","author":"Migliaccio","year":"2008","journal-title":"Exp Hematol"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0033","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/PAT.0b013e3283613dbf","article-title":"Up-regulated expression of CXCL12 in human spleens with extramedullary haematopoiesis","volume":"45","author":"Miwa","year":"2013","journal-title":"Pathology"},{"issue":"33","key":"10.1053\/j.semdp.2020.07.003_bib0034","doi-asserted-by":"crossref","first-page":"54082","DOI":"10.18632\/oncotarget.10789","article-title":"CXCL12\/CXCR4 pathway is activated by oncogenic JAK2 in a PI3K-dependent manner","volume":"8","author":"Abdelouahab","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1053\/j.semdp.2020.07.003_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030898","article-title":"Understanding Splenomegaly in Myelofibrosis: association with Molecular Pathogenesis","volume":"19","author":"Song","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1053\/j.semdp.2020.07.003_bib0036","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/modpathol.3800826","article-title":"The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders","volume":"20","author":"Hsieh","year":"2007","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2020.07.003_bib0037","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.humpath.2007.04.004","article-title":"Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis","volume":"38","author":"Konoplev","year":"2007","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2020.07.003_bib0038","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/modpathol.3800481","article-title":"Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia","volume":"18","author":"O'Malley","year":"2005","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2020.07.003_bib0039","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.3324\/haematol.2018.193763","article-title":"Genomic characterization of spleens in patients with myelofibrosis","volume":"103","author":"Zimran","year":"2018","journal-title":"Haematologica"},{"issue":"6","key":"10.1053\/j.semdp.2020.07.003_bib0040","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/modpathol.2012.33","article-title":"Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition","volume":"25","author":"Prakash","year":"2012","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2020.07.003_bib0041","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1182\/blood.V97.11.3665","article-title":"Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia","volume":"97","author":"Mesa","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2020.07.003_bib0042","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.hemonc.2016.07.002","article-title":"The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis","volume":"9","author":"Pizzi","year":"2016","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"3","key":"10.1053\/j.semdp.2020.07.003_bib0043","first-page":"263","article-title":"Spleen size in polycythemia. A clinical and scintigraphic study","volume":"191","author":"Westin","year":"1972","journal-title":"Acta Med Scand"},{"issue":"1","key":"10.1053\/j.semdp.2020.07.003_bib0044","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ajcp\/89.1.69","article-title":"Splenic hematopoiesis in polycythemia vera. A morphologic and immunohistologic study","volume":"89","author":"Wolf","year":"1988","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0045","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V65.4.803.803","article-title":"Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly","volume":"65","author":"Wolf","year":"1985","journal-title":"Blood"},{"year":"2017","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","key":"10.1053\/j.semdp.2020.07.003_bib0046"},{"issue":"3\u20134","key":"10.1053\/j.semdp.2020.07.003_bib0047","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/10428199609051762","article-title":"Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact","volume":"22","author":"Thiele","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0048","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","article-title":"Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel","volume":"110","author":"Tefferi","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2020.07.003_bib0049","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00005792-197109000-00001","article-title":"The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome","volume":"50","author":"Ward","year":"1971","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1053\/j.semdp.2020.07.003_bib0050","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/modpathol.3800480","article-title":"Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders","volume":"18","author":"O'Malley","year":"2005","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2020.07.003_bib0051","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s11899-018-0491-5","article-title":"Leukemic Transformation of Myeloproliferative Neoplasms: therapeutic and Genomic Considerations","volume":"13","author":"Li","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0052","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-6196(12)60486-8","article-title":"Essential thrombocythemia in young adults","volume":"66","author":"McIntyre","year":"1991","journal-title":"Mayo Clin Proc"},{"issue":"23","key":"10.1053\/j.semdp.2020.07.003_bib0053","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","article-title":"Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study","volume":"29","author":"Barbui","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0054","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/ajcp\/105.2.238","article-title":"Juvenile chronic myelogenous leukemia","volume":"105","author":"Hess","year":"1996","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2020.07.003_bib0055","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/00000478-199810000-00011","article-title":"Splenic pathology in myelodysplasia: a report of 13 cases with clinical correlation","volume":"22","author":"Kraus","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2020.07.003_bib0056","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2141.2010.08525.x","article-title":"Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia","volume":"152","author":"Loh","year":"2011","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.semdp.2020.07.003_bib0057","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0145-2126(03)00006-7","article-title":"Splenic histopathological patterns in chronic myelomonocytic leukemia with clinical correlations: reinforcement of the heterogeneity of the syndrome","volume":"27","author":"Steensma","year":"2003","journal-title":"Leuk Res"},{"issue":"11","key":"10.1053\/j.semdp.2020.07.003_bib0058","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/ajh.25246","article-title":"Splenectomy in patients with chronic myelomonocytic leukemia: indications, histopathological findings and clinical outcomes in a single institutional series of thirty-nine patients","volume":"93","author":"Pophali","year":"2018","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1053\/j.semdp.2020.07.003_bib0059","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41408-018-0156-6","article-title":"Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: mayo Clinic case series of 309 patients","volume":"8","author":"Fan","year":"2018","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.1053\/j.semdp.2020.07.003_bib0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00000478-198307000-00005","article-title":"Systemic mastocytosis. Extracutaneous manifestations","volume":"7","author":"Brunning","year":"1983","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0061","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/1097-0142(19920715)70:2<459::AID-CNCR2820700214>3.0.CO;2-4","article-title":"Spleen findings in generalized mastocytosis. A clinicopathologic study","volume":"70","author":"Horny","year":"1992","journal-title":"Cancer"},{"issue":"1","key":"10.1053\/j.semdp.2020.07.003_bib0062","first-page":"4","article-title":"Pathology of the lymph node and spleen in systemic mast cell disease","volume":"1","author":"Travis","year":"1988","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0063","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01606518","article-title":"Different patterns of spleen involvement in systemic and malignant mastocytosis. A histological and immunohistochemical study of three cases","volume":"419","author":"Diebold","year":"1991","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"3 Suppl","key":"10.1053\/j.semdp.2020.07.003_bib0064","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1111\/1523-1747.ep12469022","article-title":"The liver, spleen, and lymph nodes in mastocytosis","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000101711","article-title":"Mastocytosis: state of the art","volume":"74","author":"Horny","year":"2007","journal-title":"Pathobiology"},{"issue":"5","key":"10.1053\/j.semdp.2020.07.003_bib0066","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M","article-title":"Significance of systemic mast cell disease with associated hematologic disorders","volume":"62","author":"Travis","year":"1988","journal-title":"Cancer"},{"issue":"6","key":"10.1053\/j.semdp.2020.07.003_bib0067","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005792-198811000-00002","article-title":"Hematophagic histiocytosis. A report of 23 new patients and a review of the literature","volume":"67","author":"Reiner","year":"1988","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0068","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1651-2227.1991.tb11878.x","article-title":"Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatr Scand"},{"issue":"8526","key":"10.1053\/j.semdp.2020.07.003_bib0069","first-page":"208","article-title":"Writing Group of the Histiocyte Society","volume":"1","year":"1987","journal-title":"Lancet"},{"issue":"5446","key":"10.1053\/j.semdp.2020.07.003_bib0070","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"issue":"8","key":"10.1053\/j.semdp.2020.07.003_bib0071","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.3928\/19382359-20170717-01","article-title":"An Overview of Hemophagocytic Lymphohistiocytosis","volume":"46","author":"Esteban","year":"2017","journal-title":"Pediatr Ann"},{"issue":"17","key":"10.1053\/j.semdp.2020.07.003_bib0072","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1002\/cncr.30826","article-title":"A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults","volume":"123","author":"Daver","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"10.1053\/j.semdp.2020.07.003_bib0073","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.blre.2016.05.001","article-title":"Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review","volume":"30","author":"Hayden","year":"2016","journal-title":"Blood Rev"},{"key":"10.1053\/j.semdp.2020.07.003_bib0074","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic Lymphohistiocytosis","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2020.07.003_bib0075","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2559.1985.tb02877.x","article-title":"Malignant histiocytosis (true histiocytic lymphoma) clinicopathological study of 25 cases","volume":"9","author":"Pileri","year":"1985","journal-title":"Histopathology"},{"issue":"1","key":"10.1053\/j.semdp.2020.07.003_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.53.1","article-title":"Histiocytic sarcoma\u202f: an updated literature review based on the 2008 WHO classification","volume":"53","author":"Takahashi","year":"2013","journal-title":"J Clin Exp Hematop"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0077","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1078\/0344-0338-00362","article-title":"Primary histiocytic sarcoma of the spleen associated with erythrophagocytic histiocytosis","volume":"199","author":"Audouin","year":"2003","journal-title":"Pathol Res Pract"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0078","first-page":"282","article-title":"A case of histiocytic sarcoma diagnosed by bone marrow biopsy in a patient suffering from fever for 8 months","volume":"29","author":"Jang","year":"2009","journal-title":"Korean J Lab Med"},{"issue":"3A","key":"10.1053\/j.semdp.2020.07.003_bib0079","first-page":"127","article-title":"Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types","volume":"41","author":"Chan","year":"2002","journal-title":"Histopathology"},{"issue":"3","key":"10.1053\/j.semdp.2020.07.003_bib0080","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V73.3.806.806","article-title":"A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis","volume":"73","author":"Kaneko","year":"1989","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2020.07.003_bib0081","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00313028709065134","article-title":"Reactive hemophagocytic syndrome: a study of 7 fatal cases","volume":"19","author":"Chan","year":"1987","journal-title":"Pathology"},{"issue":"1","key":"10.1053\/j.semdp.2020.07.003_bib0082","first-page":"57","article-title":"Prognostic factors in histiocytosis X","volume":"3","author":"Lahey","year":"1981","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0083","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hon.2900120204","article-title":"Reactive hemophagocytic syndrome in childhood\u2013frequent occurrence of atypical mononuclear cells","volume":"12","author":"Wong","year":"1994","journal-title":"Hematol Oncol"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0084","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9343(92)90048-G","article-title":"Reactive hemophagocytic syndrome\u2013a clinicopathologic study of 40 patients in an Oriental population","volume":"93","author":"Wong","year":"1992","journal-title":"Am J Med"},{"issue":"8","key":"10.1053\/j.semdp.2020.07.003_bib0085","first-page":"1389","article-title":"Leukemia after true histiocytic lymphoma: another type of acute monocytic leukemia with histiocytic differentiation (AML-M5c)?","volume":"9","author":"Esteve","year":"1995","journal-title":"Leukemia"},{"issue":"6","key":"10.1053\/j.semdp.2020.07.003_bib0086","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41379-018-0200-x","article-title":"Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma","volume":"32","author":"Shanmugam","year":"2019","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0087","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/ijlh.13030","article-title":"Cytogenetics and associated mutation profile in patients with acute monocytic leukemia","volume":"41","author":"Xing","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0088","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3324\/haematol.2019.230375","article-title":"Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups","volume":"105","author":"Egan","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0089","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00428-016-1965-2","article-title":"Somatic mutations in histiocytic sarcoma identified by next generation sequencing","volume":"469","author":"Liu","year":"2016","journal-title":"Virchows Arch"},{"issue":"20","key":"10.1053\/j.semdp.2020.07.003_bib0090","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM199005173222004","article-title":"Hematologic neoplasia associated with primary mediastinal germ-cell tumors","volume":"322","author":"Nichols","year":"1990","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.semdp.2020.07.003_bib0091","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0046-8177(90)90028-4","article-title":"Association between mediastinal germ cell tumors and hematologic malignancies: an update","volume":"21","author":"deMent","year":"1990","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2020.07.003_bib0092","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0046-8177(88)80209-0","article-title":"Mediastinal germ cell tumors and histiocytosis","volume":"19","author":"Ladanyi","year":"1988","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2020.07.003_bib0093","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1002\/1097-0142(19930615)71:12<3873::AID-CNCR2820711214>3.0.CO;2-1","article-title":"Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors","volume":"71","author":"Orazi","year":"1993","journal-title":"Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0094","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/PAI.0b013e3181897e8e","article-title":"Malignant histiocytoses\/disseminated histiocytic sarcoma with hemophagocytic syndrome in a patient with mediastinal germ cell tumor","volume":"17","author":"Shinoda","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"10.1053\/j.semdp.2020.07.003_bib0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/106689690501300314","article-title":"Mediastinal germ cell tumor associated with histiocytic sarcoma of spleen: case report of an unusual association","volume":"13","author":"Song","year":"2005","journal-title":"Int J Surg Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2020.07.003_bib0096","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.5858\/arpa.2015-0199-RA","article-title":"Langerhans Cell Histiocytosis: a Clinicopathologic Review and Molecular Pathogenetic Update","volume":"139","author":"Harmon","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2020.07.003_bib0097","first-page":"4","article-title":"Pathology of histiocytosis X","volume":"9","author":"Jaffe","year":"1987","journal-title":"Perspect Pediatr Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2020.07.003_bib0098","first-page":"17","article-title":"The French langerhans\u2019 cell histiocytosis study group","volume":"75","year":"1996","journal-title":"Arch Dis Child"},{"volume":"16","year":"1995","author":"Callihan","key":"10.1053\/j.semdp.2020.07.003_bib0099"},{"issue":"12","key":"10.1053\/j.semdp.2020.07.003_bib0100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJM198703193161211","article-title":"Langerhans cell histiocytosis","volume":"316","author":"Komp","year":"1987","journal-title":"N Engl J Med"},{"issue":"38","key":"10.1053\/j.semdp.2020.07.003_bib0101","doi-asserted-by":"crossref","first-page":"e12378","DOI":"10.1097\/MD.0000000000012378","article-title":"Isolated Langerhans cell histiocytosis of the spleen: a case report","volume":"97","author":"Hong","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1053\/j.semdp.2020.07.003_bib0102","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jcp.49.3.262","article-title":"Langerhans cell histiocytosis forming an asymptomatic solitary nodule in the spleen","volume":"49","author":"Lam","year":"1996","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2020.07.003_bib0103","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/1097-0142(197205)29:5<1380::AID-CNCR2820290540>3.0.CO;2-7","article-title":"A cytoplasmic membranous complex in histiocytosis X","volume":"29","author":"Basset","year":"1972","journal-title":"Cancer"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0104","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/01913128209016637","article-title":"Electron microscopy in histiocytosis X","volume":"3","author":"Mierau","year":"1982","journal-title":"Ultrastruct Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3960\/jslrt.56.109","article-title":"Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma: current Understanding and Differential Diagnosis","volume":"56","author":"Nakamine","year":"2016","journal-title":"J Clin Exp Hematop"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0106","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5858\/arpa.2016-0126-RS","article-title":"Follicular Dendritic Cell Sarcoma","volume":"141","author":"Chen","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0107","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<294::AID-CNCR13>3.0.CO;2-W","article-title":"Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized","volume":"79","author":"Chan","year":"1997","journal-title":"Cancer"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0108","first-page":"144","article-title":"Follicular dendritic cell tumor: review of the entity","volume":"15","author":"Perez-Ordo\u00f1ez","year":"1998","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2020.07.003_bib0109","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/modpathol.2015.130","article-title":"Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-\u03baB regulatory genes","volume":"29","author":"Griffin","year":"2016","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2020.07.003_bib0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/his.12416","article-title":"Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms","volume":"65","author":"Go","year":"2014","journal-title":"Histopathology"},{"issue":"9","key":"10.1053\/j.semdp.2020.07.003_bib0111","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/modpathol.2017.34","article-title":"Genomic analysis of follicular dendritic cell sarcoma by molecular inversion probe array reveals tumor suppressor-driven biology","volume":"30","author":"Andersen","year":"2017","journal-title":"Modern Pathology"},{"issue":"6","key":"10.1053\/j.semdp.2020.07.003_bib0112","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/his.12851","article-title":"Clinicopathological features of inflammatory pseudotumour-like follicular dendritic cell tumour of the abdomen","volume":"68","author":"Chen","year":"2016","journal-title":"Histopathology"},{"issue":"6","key":"10.1053\/j.semdp.2020.07.003_bib0113","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00000478-200106000-00003","article-title":"Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association","volume":"25","author":"Cheuk","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2020.07.003_bib0114","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/PAS.0000000000000170","article-title":"Inflammatory pseudotumor-like follicular dendritic cell tumor of liver and spleen: granulomatous and eosinophil-rich variants mimicking inflammatory or infective lesions","volume":"38","author":"Li","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2020.07.003_bib0115","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00000478-200204000-00018","article-title":"Interdigitating dendritic cell sarcoma of the spleen: report of a case with a review of the literature","volume":"26","author":"Kawachi","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"19","key":"10.1053\/j.semdp.2020.07.003_bib0116","doi-asserted-by":"crossref","first-page":"e15535","DOI":"10.1097\/MD.0000000000015535","article-title":"Interdigitating dendritic cell sarcoma of the spleen with hepatic failure after chemotherapy: a case report","volume":"98","author":"Zhao","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257020300666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257020300666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:22:11Z","timestamp":1760037731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257020300666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0740257020300666"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2020.07.003","relation":{},"ISSN":["0740-2570"],"issn-type":[{"type":"print","value":"0740-2570"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid, mast cell, histiocytic and dendritic cell neoplasms and proliferations involving the spleen","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2020.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}